Stock News

IDEXX Laboratories, Inc. (IDXX) Touches $180.63 High on Jan, 21; Last Week The Vitec Group plc (LON:VTC) Coverage

Among 5 analysts covering Vitec Group The PLC (LON:VTC), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vitec Group The PLC had 22 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating by Investec given on Tuesday, November 17. As per Friday, November 25, the company rating was maintained by Peel Hunt. The firm earned “Buy” rating on Tuesday, February 21 by Peel Hunt. The stock of The Vitec Group plc (LON:VTC) has “Buy” rating given on Thursday, October 8 by Investec. Arden Partners maintained the shares of VTC in report on Wednesday, November 9 with “Buy” rating. The rating was maintained by Peel Hunt on Friday, August 11 with “Buy”. The stock has “Buy” rating by Investec on Thursday, February 11. Peel Hunt maintained The Vitec Group plc (LON:VTC) rating on Friday, September 29. Peel Hunt has “Buy” rating and GBX 1300 target. The firm has “Buy” rating by Peel Hunt given on Wednesday, April 5. Peel Hunt maintained The Vitec Group plc (LON:VTC) rating on Tuesday, October 31. Peel Hunt has “Buy” rating and GBX 1300 target. See The Vitec Group plc (LON:VTC) latest ratings:

16/11/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1300.00 New Target: GBX 1300.00 Maintain
31/10/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1300.00 New Target: GBX 1300.00 Maintain
29/09/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1185.00 New Target: GBX 1300.00 Maintain
06/09/2017 Broker: Berenberg Rating: Buy Maintain
14/08/2017 Broker: Berenberg Rating: Buy New Target: GBX 1150.00 Maintain
11/08/2017 Broker: Peel Hunt Rating: Buy Old Target: GBX 1185.00 New Target: GBX 1185.00 Maintain

The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) reached all time high today, Jan, 21 and still has $187.86 target or 4.00% above today’s $180.63 share price. This indicates more upside for the $15.75 billion company. This technical setup was reported by Barchart.com. If the $187.86 PT is reached, the company will be worth $630.16 million more. The stock increased 0.91% or $1.63 during the last trading session, reaching $180.63. About 602,985 shares traded or 14.40% up from the average. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since January 21, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

The Vitec Group plc designs, manufactures, and supplies services and products that enable end users to capture and share exceptional images for the broadcast and photographic markets worldwide. The company has market cap of 514.51 million GBP. The firm operates in two divisions, Broadcast and Photographic. It has a 32.71 P/E ratio. The Broadcast division provides premium branded products for broadcasting, film, and video production for broadcasters and independent content creators, including education and religious establishments, corporate entities, and governmental bodies.

The stock decreased 0.43% or GBX 5 during the last trading session, reaching GBX 1145. About 14,036 shares traded. The Vitec Group plc (LON:VTC) has 0.00% since January 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.33, from 1.19 in 2017Q2. It is negative, as 39 investors sold IDEXX Laboratories, Inc. shares while 196 reduced holdings. 55 funds opened positions while 146 raised stakes. 87.85 million shares or 15.07% more from 76.34 million shares in 2017Q2 were reported. Cubist Systematic Strategies Lc stated it has 7,662 shares. Retirement Of Alabama, Alabama-based fund reported 42,342 shares. Parkside Bancorporation & owns 154 shares. Dnb Asset As holds 0.04% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 18,360 shares. Comml Bank Of Montreal Can, Ontario – Canada-based fund reported 353,001 shares. Stevens Mgmt L P invested 0.05% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Fiera Capital Corporation invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Scotia holds 0.01% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 3,477 shares. Southeast Asset Advisors holds 0.08% or 1,617 shares. Bokf Na, Oklahoma-based fund reported 4,819 shares. Stifel Fincl invested in 0.01% or 19,884 shares. State Street Corp reported 3.71 million shares. Bath Savings invested in 1.29% or 31,149 shares. Cardinal Capital reported 18,796 shares. Liberty Mutual Asset Mgmt holds 0.03% or 3,574 shares in its portfolio.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on February, 1. They expect $0.73 earnings per share, up 25.86% or $0.15 from last year’s $0.58 per share. IDXX’s profit will be $63.67M for 61.86 P/E if the $0.73 EPS becomes a reality. After $0.79 actual earnings per share reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts -7.59% negative EPS growth.

Since August 8, 2017, it had 0 insider buys, and 6 insider sales for $26.12 million activity. The insider AYERS JONATHAN W sold 54,000 shares worth $8.96 million. Shares for $790,342 were sold by HENDERSON REBECCA M on Tuesday, August 22.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $15.75 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 58.68 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

Among 10 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 6 have Buy rating, 2 Sell and 2 Hold. Therefore 60% are positive. IDEXX Laboratories had 23 analyst reports since July 24, 2015 according to SRatingsIntel. CL King initiated the stock with “Neutral” rating in Friday, April 1 report. The stock has “Buy” rating by Stifel Nicolaus on Monday, August 21. The firm earned “Buy” rating on Monday, August 21 by Canaccord Genuity. Canaccord Genuity maintained it with “Buy” rating and $180.0 target in Thursday, October 5 report. The firm has “Neutral” rating given on Thursday, September 29 by Bank of America. On Thursday, July 23 the stock rating was maintained by Canaccord Genuity with “Buy”. Stifel Nicolaus maintained the shares of IDXX in report on Monday, March 21 with “Buy” rating. On Wednesday, August 23 the stock rating was upgraded by Bank of America to “Buy”. The rating was upgraded by C.L. King on Friday, July 28 to “Buy”. The company was downgraded on Friday, August 28 by Raymond James.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *